van der Hoeven Sophia, Ball Lorenzo, Constantino Federico, van Meenen David M, Pelosi Paolo, Beenen Ludo F, Schultz Marcus J, Paulus Frederique
Department of Intensive Care, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, The Netherlands.
Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.
Intensive Care Med Exp. 2020 Dec 18;8(Suppl 1):71. doi: 10.1186/s40635-020-00351-x.
Accumulated airway secretions in the endotracheal tube increase work of breathing and may favor airway colonization eventually leading to pneumonia. The aim of this preplanned substudy of the 'Preventive Nebulization of Mucolytic Agents and Bronchodilating Drugs in Intubated and Ventilated Intensive Care Unit Patients trial' (NEBULAE) was to compare the effect of routine vs on-demand nebulization of acetylcysteine with salbutamol on accumulation of secretions in endotracheal tubes in critically ill patients.
In this single-center substudy of a national multicenter trial, patients were randomized to a strategy of routine nebulizations of acetylcysteine with salbutamol every 6 h until end of invasive ventilation, or to a strategy with on-demand nebulizations of acetylcysteine or salbutamol applied on strict clinical indications only. The primary endpoint, the maximum reduction in cross-sectional area (CSA) of the endotracheal tube was assessed with high-resolution computed tomography. Endotracheal tubes were collected from 72 patients, 36 from patients randomized to the routine nebulization strategy and 36 of patients randomized to the on-demand nebulization strategy. The maximum cross-sectional area (CSA) of the endotracheal tube was median 12 [6 to 15]% in tubes obtained from patients in the routine nebulization group, not different from median 9 [6 to 14]% in tubes obtained from patients in the on-demand nebulization group (P = 0.33).
In adult critically ill patients under invasive ventilation, routine nebulization of mucolytics and bronchodilators did not affect accumulation of airway secretions in the endotracheal tube. Trial registration Clinicaltrials.gov Identifier: NCT02159196.
气管内导管中积聚的气道分泌物会增加呼吸功,并可能促进气道定植,最终导致肺炎。“预防雾化黏液溶解剂和支气管扩张药物用于插管和机械通气的重症监护病房患者试验”(NEBULAE)这项预先计划的子研究旨在比较常规雾化与按需雾化乙酰半胱氨酸联合沙丁胺醇对重症患者气管内导管分泌物积聚的影响。
在这项全国多中心试验的单中心子研究中,患者被随机分为两种策略,一种是每6小时常规雾化乙酰半胱氨酸联合沙丁胺醇直至有创通气结束,另一种是仅在严格临床指征下按需雾化乙酰半胱氨酸或沙丁胺醇。主要终点是通过高分辨率计算机断层扫描评估气管内导管横截面积(CSA)的最大减小值。从72例患者中收集了气管内导管,其中36例来自随机分配至常规雾化策略的患者,36例来自随机分配至按需雾化策略的患者。常规雾化组患者的气管内导管最大横截面积(CSA)中位数为12[6至15]%,与按需雾化组患者的气管内导管中位数9[6至14]%无差异(P = 0.33)。
在接受有创通气的成年重症患者中,常规雾化黏液溶解剂和支气管扩张剂对气管内导管气道分泌物的积聚没有影响。试验注册Clinicaltrials.gov标识符:NCT02159196。